Multiple lineage switches in KMT2A rearranged infant leukemia, responsive to combination therapy with CPX-351 and inotuzumab.

Sperlazza, Justin; Galeotti, Jonathan; Hucks, George; Alexander, Thomas B

Sperlazza, Justin; Galeotti, Jonathan; Hucks, George; Alexander, Thomas B.

Afiliación

Sperlazza J; Division of Pediatric Hematology-Oncology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
Galeotti J; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
Hucks G; Division of Pediatric Hematology-Oncology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
Alexander TB; Division of Pediatric Hematology-Oncology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.

Pediatr Blood Cancer ; 70(11): e30645, 2023 11.

Article en En | MEDLINE | ID: mdl-37638847

Asunto(s)

Citarabina; Leucemia; Lactante; Humanos; Daunorrubicina

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia / Citarabina Límite: Humans / Infant Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google